Literature DB >> 29741284

Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss.

Camille M Parsons1, Andrew Judge2, Kirsten Leyland3, Olivier Bruyère4, Florence Petit Dop5, Roland Chapurlat6, Jean-Yves Reginster4, Mark H Edwards7, Elaine M Dennison1, Cyrus Cooper8, Hazel Inskip9.   

Abstract

OBJECTIVE: Osteoarthritis-related changes in joint space measurements over time are small and sensitive to measurement error. The Reliable Change Index (RCI) determines whether the magnitude of change observed in an individual can be attributed to true change. This study aimed to examine the RCI as a novel approach to estimating osteoarthritis progression.
METHODS: Data were from 167 men and 392 women with knee osteoarthritis (diagnosed using the American College of Rheumatology criteria) randomized to the placebo arm of the 3-year Strontium Ranelate Efficacy in Knee Osteoarthritis trial (SEKOIA) and assessed annually. The RCI was used to determine whether the magnitude of change in joint space width (JSW) on radiographs between study years was likely to be true or due to measurement error.
RESULTS: Between consecutive years, 57-69% of participants had an apparent decrease (change <0) in JSW, while 31-43% of participants had annual changes indicating improvement in JSW. The RCI identified JSW decreases in only 6.0% of patients between baseline and year 1, and in 4.5% of patients between the remaining study years. The apparent increases in JSW were almost eliminated between baseline and year 1, and between years 1 and 2 only 1.3% of patients had a significant increase, dropping to 0.9% between years 2 and 3.
CONCLUSION: The RCI provides a method to identify change in JSW, removing many apparent changes that are likely to be due to measurement error. This method appears to be useful for assessing change in JSW from radiographs in clinical and research settings.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29741284      PMCID: PMC6129388          DOI: 10.1002/acr.23596

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  26 in total

Review 1.  Clinical significance: history, application, and current practice.

Authors:  B M Ogles; K M Lunnen; K Bonesteel
Journal:  Clin Psychol Rev       Date:  2001-04

2.  Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.

Authors:  Robert J Ferguson; Amy B Robinson; Mark Splaine
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

3.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

4.  Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study.

Authors:  O Bruyere; F Richy; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

5.  Radiologic assessment of age-related knee joint space changes in women: a 4-year longitudinal study.

Authors:  Déborah Gensburger; Monique Arlot; Elisabeth Sornay-Rendu; Jean-Paul Roux; Pierre Delmas
Journal:  Arthritis Rheum       Date:  2009-03-15

Review 6.  Classification of disease: osteoarthritis.

Authors:  R D Altman
Journal:  Semin Arthritis Rheum       Date:  1991-06       Impact factor: 5.532

7.  Parametric and non-parametric measures in the assessment of knee and hip osteoarthritis: interobserver reliability and correlation with radiology.

Authors:  R Theiler; G Stucki; R Schütz; H Hofer; B Seifert; A Tyndall; B A Michel
Journal:  Osteoarthritis Cartilage       Date:  1996-03       Impact factor: 6.576

8.  Patient-reported outcomes one year after primary hip replacement in a European Collaborative Cohort.

Authors:  Andy Judge; Cyrus Cooper; Sue Williams; Karsten Dreinhoefer; Paul Dieppe
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

9.  OARSI-FDA initiative: defining the disease state of osteoarthritis.

Authors:  N E Lane; K Brandt; G Hawker; E Peeva; E Schreyer; W Tsuji; M C Hochberg
Journal:  Osteoarthritis Cartilage       Date:  2011-03-23       Impact factor: 6.576

10.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01
View more
  2 in total

1.  Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats.

Authors:  Ruotian Zhang; Min Yang; Yang Li; Hedong Liu; Maoxian Ren; Zhou-Shan Tao
Journal:  J Orthop Surg Res       Date:  2021-01-06       Impact factor: 2.359

2.  The combination of an inflammatory peripheral blood gene expression and imaging biomarkers enhance prediction of radiographic progression in knee osteoarthritis.

Authors:  Mukundan Attur; Svetlana Krasnokutsky; Hua Zhou; Jonathan Samuels; Gregory Chang; Jenny Bencardino; Pamela Rosenthal; Leon Rybak; Janet L Huebner; Virginia B Kraus; Steven B Abramson
Journal:  Arthritis Res Ther       Date:  2020-09-10       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.